With over 20,000 published studies, omega-3 is the most extensively researched supplement in existence. The evidence base covers cardiovascular disease, cognitive function, inflammation, depression, eye health, and pregnancy outcomes. No other supplement comes close in depth or breadth of clinical evidence. Yet most European adults are deficient, most European diets provide inadequate amounts, and most fish oil supplements sold in European pharmacies and supermarkets deliver the wrong form at the wrong dose.
This guide cuts through the noise. It covers the biochemistry you need to understand why form matters, the clinical data on optimal dosing, and a practical purchasing guide for buyers in the EU, UK, Switzerland, and Norway.
Why Omega-3 Is the Most Evidence-Backed Supplement
The research on omega-3 fatty acids spans decades and covers every major chronic disease category. The cardiovascular evidence alone is extensive: published research indicates that higher omega-3 intake is associated with reduced triglyceride levels, lower platelet aggregation, improved endothelial function, and reduced risk of fatal cardiac events. A landmark analysis by Harris et al. (2009) in Preventive Medicine introduced the Omega-3 Index as a cardiovascular risk biomarker, proposing that an index below 4% constitutes high risk, 4–8% intermediate risk, and above 8% low risk. Most European adults test in the 4–6% range.
On the neurological side, Mozaffarian & Wu (2011) in JACC conducted a comprehensive review concluding that omega-3 fatty acids “modulate multiple cardiometabolic risk pathways, including inflammation, lipids, thrombosis, arrhythmia, endothelial function, and oxidative stress.” Separately, studies in cognitive decline suggest DHA is required for maintaining neuronal membrane fluidity and synaptic signalling, with deficiency accelerating age-related cognitive deterioration.
Anti-inflammatory effects operate through a distinct mechanism: EPA and DHA are precursors to specialised pro-resolving mediators (SPMs) — molecules called resolvins, protectins, and maresins that actively resolve inflammation rather than simply suppressing it. This is mechanistically different from anti-inflammatory drugs, which block inflammatory signalling. Omega-3s help the immune system complete its inflammatory cycle and return to baseline.
EPA vs DHA: Different Functions, Different Targets
Omega-3 fish oil contains two primary active fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). They are chemically similar — both are long-chain polyunsaturated fatty acids — but they serve different physiological roles. Conflating them leads to suboptimal supplementation.
EPA: The Anti-Inflammatory and Mood Fatty Acid
EPA is the primary driver of omega-3's anti-inflammatory effects. It competes with arachidonic acid (the pro-inflammatory omega-6 fatty acid) for the same enzymes, reducing the production of pro-inflammatory eicosanoids. EPA is also the primary omega-3 precursor to resolvins, which actively resolve inflammation.
Critically, EPA appears to be the dominant fatty acid for mood regulation. Published research indicates that EPA has more robust effects on depression than DHA when studied separately. A meta-analysis by Sublette et al. found that formulations with at least 60% EPA relative to DHA showed significant antidepressant effects, while DHA-dominant formulations did not. This has practical implications: for mood or inflammatory conditions, an EPA-dominant product (EPA:DHA ratio of 2:1 or higher) is preferable.
DHA: The Brain Structural Fatty Acid
DHA is the primary structural fatty acid in the brain and retina. Approximately 97% of the omega-3 fatty acids in brain tissue are DHA. It is not primarily anti-inflammatory in the same acute sense as EPA — its role is maintaining the physical structure and fluidity of neuronal membranes, enabling efficient signal transduction.
DHA is critical during pregnancy and early childhood (it is why it is added to infant formula), but its structural role continues throughout life. Research suggests DHA is the more important fatty acid for long-term neurological protection and cognitive maintenance, while EPA handles acute inflammatory states and mood.
For most general supplementation purposes, a balanced EPA:DHA ratio of approximately 2:1 is the practical starting point. Specific conditions may warrant adjusting this ratio.
| Fatty Acid | Primary Role | Key Target | Ideal For |
|---|---|---|---|
| EPA | Anti-inflammatory, mood regulation | Eicosanoid pathways, SPM synthesis | Inflammation, depression, triglycerides |
| DHA | Structural brain/retinal fatty acid | Neuronal membranes, synaptic function | Cognitive maintenance, brain health, pregnancy |
| Both (2:1 EPA:DHA) | Comprehensive omega-3 coverage | Cardiovascular, brain, inflammation | General supplementation |
Triglyceride (rTG) vs Ethyl Ester (EE) Forms: Why This Is the Most Important Decision
Most people buying fish oil focus on EPA and DHA content per capsule. Far fewer pay attention to the molecular form — and yet form is the single most impactful variable on how much of that EPA and DHA actually reaches your bloodstream.
Natural Triglyceride Form
In whole fish, omega-3 fatty acids exist as triglycerides: three fatty acid chains attached to a glycerol backbone. This is the form human digestive enzymes evolved to process. It is absorbed efficiently through the standard fat digestion pathway involving pancreatic lipase.
Ethyl Ester (EE) Form
Processing fish oil to increase EPA and DHA concentration requires cleaving the fatty acids from the glycerol backbone and attaching them to ethanol molecules instead — creating ethyl esters. This is cheaper to manufacture and allows very high EPA+DHA concentrations per capsule. However, ethyl esters are synthetic molecules that do not exist in nature and are absorbed significantly less efficiently than triglycerides. The enzymatic pathway is less well adapted to processing them.
Dyerberg et al. (2010) conducted a randomised crossover trial comparing bioavailability of five different omega-3 forms. Reesterified triglycerides (rTG) showed approximately 124% bioavailability compared to EE (set at 100%). Free fatty acids showed 91%, natural triglycerides 73%, and phospholipids 69% — the EE reference. Put simply: rTG fish oil delivers roughly 70% more omega-3 to your blood compared to the same dose in EE form.
Reesterified Triglyceride (rTG) Form
The reesterified triglyceride form starts as ethyl ester (for concentration purposes), then re-attaches the fatty acids to a glycerol backbone to recreate a natural triglyceride structure. This combines the high EPA+DHA concentration possible with processing and the superior absorption of the triglyceride form. It costs more to manufacture, which is why it is found in premium products rather than supermarket brands.
Optimal Dosing: What the Evidence Supports
The most important number is combined EPA+DHA per day — not the total fish oil capsule weight, which includes filler oils and the fatty acid backbone. A capsule labelled “1000 mg fish oil” may contain only 300 mg of combined EPA+DHA. Always read the supplement facts.
General Maintenance: 1–2g EPA+DHA/day
Published research supports 1–2g combined EPA+DHA per day as effective for general cardiovascular maintenance, mild anti-inflammatory benefit, and maintaining an Omega-3 Index in the target range for most adults. The European Food Safety Authority (EFSA) has concluded that supplemental intakes up to 5g EPA+DHA per day are safe for adults.
Therapeutic and Corrective Dosing: 2–4g EPA+DHA/day
Studies targeting triglyceride reduction, depression, and significant anti-inflammatory effects typically use 2–4g EPA+DHA per day. For European adults starting from a low Omega-3 Index baseline (4–5%), a corrective period of 3–4 months at 2–3g EPA+DHA per day is a reasonable approach before dropping to a maintenance dose.
Most European Diets Are Deficient
Average omega-3 intake across Europe is well below therapeutic thresholds. Countries with traditionally high fish consumption (Norway, Iceland, coastal Spain, Portugal) are exceptions, but for the majority of Central and Eastern European populations and UK urban populations, dietary EPA+DHA intake is often below 200–300mg/day. The typical European Omega-3 Index sits at 4–6%, with the target range being 8–12%. This gap is not closeable through diet alone without eating fatty fish four or more times per week.
How to Take Omega-3: Practical Protocol
Take With Fat
Omega-3 fatty acids are fat-soluble. Absorption is substantially improved when taken with a fat-containing meal. A 2019 study found that taking omega-3 with a high-fat meal increased EPA bioavailability by approximately 60% compared to a fasted state. Do not take fish oil on an empty stomach.
Split Morning and Evening Doses
For doses above 2g EPA+DHA per day, splitting the dose between morning and evening is advisable. This improves absorption (the digestive system has a capacity limit for processing fats at any one time) and is the most effective strategy for reducing the fishy reflux that many people find off-putting. Taking the evening dose with dinner rather than before bed further reduces this effect.
Enteric-Coated Capsules
Enteric-coated fish oil capsules dissolve in the small intestine rather than the stomach, which virtually eliminates fishy burps. They cost slightly more but are a practical solution for anyone who has avoided omega-3 supplementation for this reason.
Where to Buy Quality Omega-3 in Europe
EU buyers have historically been underserved compared to the US market, but the landscape has improved significantly. These brands are consistently available across the EU via direct shipping, Amazon EU, or iHerb, which ships to most European countries.
Nordic Naturals
The most widely recognised omega-3 brand globally for quality. All products are in rTG form, third-party tested, and Friends of the Sea certified. Their Ultimate Omega (1280mg EPA+DHA per 2 softgels) and ProOmega 2000 (2000mg EPA+DHA per 2 softgels) are the most cited in the professional community. Available on iHerb with EU shipping and Amazon.de. Expect to pay €30–55 for a 60-count bottle.
Wiley's Finest
An Alaskan-sourced brand using wild-caught fish. Available in both rTG and EE forms — confirm you are selecting the Wild Alaskan or Bold EPA products, which are rTG. Widely available through iHerb for EU delivery. Strong value for the concentration offered.
Bare Biology
A UK-based premium brand that has expanded EU distribution significantly. Their Life & Soul liquid and Lion Heart capsules use rTG-form oil from Norwegian anchovies and sardines. Marine Stewardship Council (MSC) certified. Bare Biology ships direct to EU addresses and is stocked by UK online health retailers.
Pharmax / Genestra (Professionals)
Professional-grade brands available through European health practitioners and some specialist online retailers. Very high EPA+DHA concentration, rTG form, rigorous third-party testing. Used frequently in clinical practice across Northern and Western Europe.
Sustainability: What the Certifications Mean
The marine sustainability of fish oil production is a legitimate concern. Irresponsible sourcing depletes fish populations that form the base of marine food chains. Two certifications are the baseline standard for European buyers:
- MSC (Marine Stewardship Council): The gold standard for wild-caught fish. Certifies sustainable fishing practices and chain of custody. Look for the blue MSC logo on the packaging or product listing.
- Friend of the Sea: Certifies sustainable fishing and aquaculture. More common on European omega-3 brands than MSC in some categories.
Both certifications require independent audits and have genuine standards. Products from Norway and Iceland — major omega-3 producing regions for European supply — generally perform well on sustainability metrics due to stricter national fishing regulations. Avoid products with no sustainability certification and opaque sourcing.
The Vegan Alternative: Algae Oil
Fish do not synthesise omega-3 fatty acids from scratch. They accumulate EPA and DHA by eating microalgae, which are the original source. Algae oil cuts out the middleman: it sources EPA and DHA directly from the microalgae where fish get them from.
For vegans and vegetarians — a growing segment of the European market — algae oil is not a compromise. Published research indicates DHA from algae oil is bioequivalent to DHA from fish oil. Several algae oil products now offer meaningful EPA content in addition to DHA, though EPA concentrations in algae oil have historically been lower than fish oil equivalents.
Available European algae oil brands include Testa Omega-3 (Netherlands, widely available across EU), Opti3, and several Nordic Naturals algae-based options. Expect to pay a premium over fish oil for comparable EPA+DHA doses.
Blood Testing: The Omega-3 Index
The Omega-3 Index, as described by Harris & Von Schacky (2004) and expanded in Harris et al. (2009), measures EPA+DHA as a percentage of total red blood cell fatty acids. It reflects long-term omega-3 status over the preceding 8–12 weeks, analogous to HbA1c for blood glucose.
Target range: 8–12%. Most Europeans test at 4–6%. An index below 4% is associated with significantly elevated cardiovascular risk. Testing is available in Europe through several providers:
- OmegaQuant (US-based, ships kits to Europe, analysis returned digitally)
- Norsan Omega-3 Index Test (widely marketed in DACH countries — Germany, Austria, Switzerland)
- Cerascreen Omega-3 Test (available in Germany, Austria, Switzerland, UK)
Testing every 6 months while optimising your omega-3 status provides objective feedback on whether your dosing strategy is working. Most people reach target range after 3–6 months of consistent supplementation at 2g+ EPA+DHA daily.
Key Takeaways
- Omega-3 fish oil is the most evidence-backed supplement in existence, with over 20,000 studies covering cardiovascular, neurological, and inflammatory endpoints.
- EPA and DHA serve different functions: EPA for inflammation and mood, DHA for brain structure. A 2:1 EPA:DHA ratio is a practical general starting point.
- Molecular form matters substantially. rTG form absorbs approximately 70% better than ethyl ester. Always check the form, not just EPA+DHA content.
- Take 1–3g combined EPA+DHA per day with fat-containing meals. Split doses morning and evening at higher amounts.
- Most European adults have an Omega-3 Index of 4–6%, well below the 8–12% target. Corrective dosing typically requires 3–6 months at 2g+ EPA+DHA daily.
- Nordic Naturals, Wiley's Finest, and Bare Biology are reliably available across Europe in rTG form with sustainability certifications.
- Algae oil is a bioequivalent alternative for vegans and vegetarians.
Sources
- Harris WS, et al. Omega-3 Fatty Acids and Coronary Heart Disease Risk: Clinical and Mechanistic Perspectives. Atherosclerosis. 2008. pubmed.ncbi.nlm.nih.gov/18541598
- Mozaffarian D, Wu JH. Omega-3 Fatty Acids and Cardiovascular Disease. J Am Coll Cardiol. 2011;58(20):2047–2067. pubmed.ncbi.nlm.nih.gov/21798095
- Dyerberg J, et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137–141. pubmed.ncbi.nlm.nih.gov/20638827
- Harris WS, Von Schacky C. The Omega-3 Index: A New Risk Factor for Death from Coronary Heart Disease? Prev Med. 2004;39(1):212–220. pubmed.ncbi.nlm.nih.gov/15208005
- Sublette ME, et al. Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression. J Clin Psychiatry. 2011. pubmed.ncbi.nlm.nih.gov/21939614
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the Tolerable Upper Intake Level of Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA) and Docosapentaenoic Acid (DPA). EFSA Journal. 2012. efsa.onlinelibrary.wiley.com
- Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013;89(1):1–8. pubmed.ncbi.nlm.nih.gov/23796535
- Bradberry JC, Hilleman DE. Overview of Omega-3 Fatty Acid Therapies. P T. 2013;38(11):681–691. PMC3875260
